These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1400 related articles for article (PubMed ID: 25609010)

  • 1. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.
    Yang T; Martin P; Fogarty B; Brown A; Schurman K; Phipps R; Yin VP; Lockman P; Bai S
    Pharm Res; 2015 Jun; 32(6):2003-14. PubMed ID: 25609010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
    Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
    J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
    Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
    Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
    Lakkadwala S; Singh J
    Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.
    Al-Shehri A; Favretto ME; Ioannou PV; Romero IA; Couraud PO; Weksler BB; Parker TL; Kallinteri P
    Pharm Res; 2015 Mar; 32(3):1072-83. PubMed ID: 25236341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.
    Raymond AD; Diaz P; Chevelon S; Agudelo M; Yndart-Arias A; Ding H; Kaushik A; Jayant RD; Nikkhah-Moshaie R; Roy U; Pilakka-Kanthikeel S; Nair MP
    J Neurovirol; 2016 Apr; 22(2):129-39. PubMed ID: 26631079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental study on biodegradable polymer-paclitaxel conjugate micelles for chemotherapy of C6 glioma.
    Wang Z; Hu X; Yue J; Jing X
    J Control Release; 2011 Nov; 152 Suppl 1():e41-2. PubMed ID: 22195914
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma.
    Li XY; Zhao Y; Sun MG; Shi JF; Ju RJ; Zhang CX; Li XT; Zhao WY; Mu LM; Zeng F; Lou JN; Lu WL
    Biomaterials; 2014 Jul; 35(21):5591-604. PubMed ID: 24726749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment.
    Duong HH; Yung LY
    Int J Pharm; 2013 Sep; 454(1):486-95. PubMed ID: 23792465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
    Wang J; Yeung BZ; Cui M; Peer CJ; Lu Z; Figg WD; Guillaume Wientjes M; Woo S; Au JL
    J Control Release; 2017 Dec; 268():147-158. PubMed ID: 29054369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and developmental analysis of the blood-brain barrier in zebrafish.
    Jeong JY; Kwon HB; Ahn JC; Kang D; Kwon SH; Park JA; Kim KW
    Brain Res Bull; 2008 Mar; 75(5):619-28. PubMed ID: 18355638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
    Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K
    Int J Pharm; 2024 Jul; 660():124262. PubMed ID: 38815637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster of Differentiation 46 Is the Major Receptor in Human Blood-Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28).
    Kuroda H; Tachikawa M; Yagi Y; Umetsu M; Nurdin A; Miyauchi E; Watanabe M; Uchida Y; Terasaki T
    Mol Pharm; 2019 Jan; 16(1):292-304. PubMed ID: 30452273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system.
    Zou D; Wang W; Lei D; Yin Y; Ren P; Chen J; Yin T; Wang B; Wang G; Wang Y
    Int J Nanomedicine; 2017; 12():4879-4889. PubMed ID: 28744122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma.
    Zhu L; Kalimuthu S; Gangadaran P; Oh JM; Lee HW; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
    Theranostics; 2017; 7(10):2732-2745. PubMed ID: 28819459
    [No Abstract]   [Full Text] [Related]  

  • 20. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.